Skip to main content
Back
Watch Compare

Cryoport, Inc.

Data quality: 100%
CYRX
Nasdaq Manufacturing Chemicals
$9.72
▲ $0.49 (5.31%)
Mkt Cap: 486.67 M
Price
$9.72
Mkt Cap
486.67 M
Day Range
$9.09 — $9.72
52-Week Range
$5.01 — $11.45
Volume
225,970
Open $9.21
50D / 200D Avg
$8.58
13.24% above
50D / 200D Avg
$8.89
9.38% above

Quick Summary

Key Takeaways

ROE of 15.22% — decent returns on equity
Net margin of 44.44% shows strong profitability
Negative free cash flow of -25.02 M
P/E of 6.22 — trading at a low valuation
Capital efficient — spends only 9.33% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-22.86%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
15.22%
Above sector avg (-51.02%)
ROIC-3.91%
Net Margin44.44%
Op. Margin-20.89%

Safety

Debt / Equity
N/A
Current Ratio15.77
Interest Coverage-15.59

Valuation

PE (TTM)
6.22
Above sector avg (-1.98)
P/B Ratio0.95
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E 6.2 -2.0
P/B 1.0 5.1
ROE % 15.2 -51.0
Net Margin % 44.4 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.03% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -22.86% Revenue Growth (3Y) -13.09%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 176.18 M Net Income (TTM) 78.30 M
ROE 15.22% ROA 10.11%
Gross Margin 47.14% Operating Margin -20.89%
Net Margin 44.44% Free Cash Flow (TTM) -25.02 M
ROIC -3.91% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 15.77
Interest Coverage -15.59 Asset Turnover 0.23
Working Capital 454.09 M Tangible Book Value 349.61 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 6.22 Forward P/E N/A
P/B Ratio 0.95 P/S Ratio 2.76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5.14%
Market Cap 486.67 M Enterprise Value 230.86 M
Per Share
EPS (Diluted TTM) 1.40 Revenue / Share 3.52
FCF / Share -0.50 OCF / Share -0.17
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 9.33% FCF Conversion -31.95%
SBC-Adj. FCF -37.49 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 176.18 M 228.39 M 233.26 M 237.28 M 78.70 M
Net Income 78.30 M -114.76 M -99.59 M -37.33 M -32.69 M
EPS (Diluted) 1.40 -2.49 -2.21 -0.93 -1.94
Gross Profit 83.05 M 99.63 M 99.33 M 103.87 M 36.33 M
Operating Income -36.81 M -130.87 M -115.16 M -31.90 M -30.01 M
EBITDA — — — — —
R&D Expenses 17.04 M 17.71 M 18.04 M 15.72 M 9.48 M
SG&A Expenses 102.82 M 148.98 M 146.88 M 120.06 M 56.86 M
D&A 27.71 M 30.76 M 27.49 M 22.77 M 9.87 M
Interest Expense 2.36 M 4.11 M 5.50 M 6.14 M 2.56 M
Income Tax 1.80 M 1.28 M 239,000.0 2.24 M -45,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 764.99 M 703.49 M 957.74 M 1.04 B 552.41 M
Total Liabilities 262.35 M 301.59 M 468.72 M 482.91 M 169.71 M
Shareholders' Equity 502.64 M 401.90 M 489.02 M 555.84 M 382.70 M
Total Debt — — — — —
Cash & Equivalents 250.49 M 45.29 M 46.35 M 36.60 M 36.87 M
Current Assets 476.17 M 341.57 M 535.11 M 604.18 M 147.16 M
Current Liabilities 219.02 M 64.56 M 45.61 M 40.85 M 35.02 M